As the tide recedes from the recent Spring Budget 2023, we explore what has changed regarding R&D tax incentives and how this may impact the UK’s life sciences and biotech industry.
WHAT IS THE BACKGROUND?
Before going into detail on the research and development (R&D) tax relief changes announced, it is helpful to recap the background.
There are currently two schemes of relief:
1. Designed for small and medium-sized enterprises (SMEs) - consisting of an additional tax deduction combined with a payable credit for loss-makers; and
2. Designed for larger companies and consisting of an R…
Nottingham-based contract research organisation (CRO) Cellomatics Biosciences has been officially presented with the prestigious Queen’s Award for Enterprise for International Trade following significant growth in its export business.
Cellomatics is one of just 232 organisations nationally to be recognised with the prominent award, which this year becomes the King’s Award for Enterprise.
The company was presented with the award by the Lord Lieutenant of Nottingham, Sir John Peace, on Thursday 23 March at a ceremony hosted at Cellomatics’ Head Office in Colwick. The afternoon event was…
AMSBIO is pleased to announce the launch of Extragel, a like-for-like replacement for Matrigel™, GeltrexTM and CultrexTM Basement Membrane Extract (BME).
Available ex-stock, with overnight shipment, Extragel is a reconstituted matrix hydrogel formed by basement membrane components extracted from mouse tumor tissues which are rich in extracellular matrix proteins. Designed to be used undiluted or diluted to a specific protein concentration, Extragel is proven to be a highly effective growth scaffold for in vivo xenograft generation, pluripotent stem cell…
Press release
Macomics and Ono Pharmaceutical Partner to Discover and Develop Macrophage-targeting Antibody Therapy for the Treatment of Cancer
• Worldwide drug discovery collaboration agreement with Ono to develop new antibody drugs against a novel macrophage target of interest in immuno-oncology
• Macomics will develop antibody candidates against a novel target using its ENIGMACTM macrophage drug discovery platform
• Ono has an exclusive option to license global rights to the candidates for further development and commercialization
• Macomics will receive an up-front payment, R&D…
£250m Melbourn Science Park vision including village green for local residents unveiled with full set of artist’s impressions for future site as Bruntwood SciTech submits planning application to help supercharge Cambridgeshire’s life science and tech capacity
- Plans include a co-working hub with shared events space, gastropub and boutique hotel, village green, extensive landscaping and improved transport provision
- £250 million masterplan spanning 390,000 sq ft to include six new builds, three redevelopments and a village green
- New world class office and lab workspace will be offered…
Click here to view the March 2023 edition of The Meeting Place.
BioIVT, a leading provider of biospecimens, research models, and services for drug and diagnostic development, today announced its scientific contributions to the 2023 Society of Toxicology (SOT) 62nd Annual Meeting and ToxExpo. This year’s conference will be held from March 19-23 at the Nashville Music City Center in Nashville, TN.
“We look forward to catching up with our research colleagues at the SOT Annual Meeting and discussing recent scientific advances,” said Dr. Christopher Black, BioIVT Senior Vice President, ADME-Tox. “Our goal at BioIVT is to be the trusted partner for in vitro…
CN Bio appoints Deepak Singh as Vice President of Sales and Marketing
Key appointment as company seeks to continue global expansion of microphysiological systems and contract research service offerings
Cambridge, UK, 14 March 2023: CN Bio, a leading Organ-on-a-chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), has today announced that is has appointed Deepak Singh as Vice President of Sales and Marketing. Deepak’s appointment supports the Company’s next phase of commercial development as it expands international operations, product…
Leading Scientists Discuss 3D Organoid Culture Research
AMSBIO has interviewed two extraordinary women in the 3D Cell Culture and Organoid field; Dr Hynda Kleinman, one of the co-inventors of Matrigel, and Dr Meritxell Huch, a director at the Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG) to mark International Women’s Day on the 8th March, and World Organoid Research Day on 22nd March 2023.
Topics covered in this informative interview include: how they got into 3D organoid culture research; their experiences in the field and how the field has changed; challenges they…
ValiRx PLC, a life science company focused on early-stage cancer therapeutics and women's health, has announced three senior appointments to its newly incorporated subsidiary company, Inaphaea BioLabs (Inaphaea).
Headquartered in MediCity Nottingham, Inaphaea will offer a wide range of pre-clinical and drug discovery testing services to academic, biotech and pharmaceutical researchers, forming the foundation of ValiRx’s tCRO™ (translational Contract Research Organisation) strategy.
As a wholly owned subsidiary of ValiRx, Inaphaea will have the capability to conduct in vitro and ex vivo…